G. Pluhar Veterinary Clinical Sciences, University of Minnesota, USA
1 protocol

Michael Olin Department of Pediatrics, University of Minnesota, USA
1 protocol

Brian Andersen Department of Pediatrics, University of Minnesota, USA
1 protocol

Michelle R. Goulart
  • Veterinary Clinical Sciences, University of Minnesota, USA
Research focus
  • Cancer biology
  • 1 Author merit


Ph.D. in Veterinary Medicine, University of Minnesota, Saint Paul, MN, USA (scheduled for 05/2014)
D.V.M., Residency Program, Small Animal Surgery, Universidade Federal de Uberlandia, MG, Brazil, 2008

Current position

Research Assistant (Ph.D. candidate), Veterinary Clinical Sciences Department, College of Veterinary Medicine, University of Minnesota


  1. Andersen, B. M., Pluhar, G. E., Seiler, C. E., Goulart, M. R., SantaCruz, K. S., Schutten, M. M., Meints, J. P., O'Sullivan, M. G., Bentley, R. T., Packer, R. A., Thomovsky, S. A., Chen, A. V., Faissler, D., Chen, W., Hunt, M. A., Olin, M. R. and Ohlfest, J. R. (2013). Vaccination for invasive canine meningioma induces in situ production of antibodies capable of antibody-dependent cell-mediated cytotoxicity. Cancer Res 73(10): 2987-2997.
  2. Goulart, M. R., Pluhar, G. E. and Ohlfest, J. R. (2012). Identification of myeloid derived suppressor cells in dogs with naturally occurring cancer. PLoS One 7(3): e33274.
  3. Pluhar, G. E., Grogan, P. T., Seiler, C., Goulart, M., Santacruz, K. S., Carlson, C., Chen, W., Olin, M. R., Lowenstein, P. R., Castro, M. G., Haines, S. J. and Ohlfest, J. R. (2010). Anti-tumor immune response correlates with neurological symptoms in a dog with spontaneous astrocytoma treated by gene and vaccine therapy. Vaccine 28(19): 3371-3378.
1 Protocol published
Authors:  Brian M. Andersen, Michelle R. Goulart, Michael R. Olin and G. Elizabeth Pluhar, date: 05/05/2014, view: 7012, Q&A: 0
Vaccine-based immunotherapy is being used to treat dogs with primary brain tumors. The vaccines are composed of a lysate of autologous tumor cells, which stimulate an immune response producing tumor specific antibodies that are capable of inducing ...
We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.